Methylation of the p73 gene in patients with myelodysplastic syndromes: Correlations with apoptosis and prognosis

Tumor Biology

Volumn 34, Issue 1, 2013, Pages 165-172

  Zhao, Youshan ^a   Fei, Chengming ^a   Zhang, Xi ^a   Zhang, Yao ^a   Guo, Juan ^a   Gu, Shucheng ^a   Li, Xiao ^a   Chang, Chunkang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; MDS; Methylation; p73; Prognosis

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; PROTEIN P73;

ADULT; AGED; APOPTOSIS; ARTICLE; BLAST CELL; BONE MARROW CELL; BONE MARROW EXAMINATION; CONTROLLED STUDY; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; P73 GENE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; TRANSCRIPTION REGULATION;

EID: 84872766973     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0524-y     Document Type: Article

References (35)

1. SD Nimer 2008 Myelodysplastic syndromes Blood 111 4841 51 18467609 10.1182/blood-2007-08-078139 1:CAS:528:DC%2BD1cXmtlaitb0%3D
2. WK Hofmann S de Vos M Komor D Hoelzer W Wachsman HP Koeffler 2002 Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow Blood 100 3553 60 12411319 10.1182/blood.V100.10. 3553 1:CAS:528:DC%2BD38XoslKmtbg%3D
3. O Hopfer M Komor IS Koehler, et al. 2007 DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation Exp Hematol 35 712 23 17577921 10.1016/j.exphem.2007.01.054 1:CAS:528:DC%2BD2sXmt1egsrY%3D
4. JPJ Issa 2007 DNA methylation as a therapeutic target in cancer Clin Cancer Res 13 1634 7 17363514 10.1158/1078-0432.CCR-06-2076 1:CAS:528: DC%2BD2sXivV2gtr8%3D
5. JG Herman SB Baylin 2003 Gene silencing in cancer in association with promoter hypermethylation N Engl J Med 349 2042 54 14627790 10.1056/NEJMra023075 1:CAS:528:DC%2BD3sXptFKmu7s%3D
6. Y Jiang A Dunbar LP Gondek, et al. 2009 Aberrant DNA methylation is a dominant mechanism in MDS progression to AML Blood 113 1315 25 18832655 10.1182/blood-2008-06-163246 1:CAS:528:DC%2BD1MXitV2ru78%3D
7. Y Yoshida 2007 A new look at apoptosis in MDS: an uneasy neighbor Leuk Res 31 1617 17692912 10.1016/j.leukres.2007.06.003
8. DB Kerbauy HJ Deeg 2007 Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome Exp Hematol 35 1739 46 17976524 10.1016/j.exphem.2007.09.007 1:CAS:528:DC%2BD2sXht1KrtLjN
9. M Kaghad H Bonnet A Yang, et al. 1997 Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 90 809 19 9288759 10.1016/S0092-8674(00)80540-1 1:CAS:528:DyaK2sXlvFKmurY%3D
10. S Ramadan A Terrinoni MV Catani, et al. 2005 p73 induces apoptosis by different mechanisms Biochem Biophys Res Commun 331 713 7 15865927 10.1016/j.bbrc.2005.03.156 1:CAS:528:DC%2BD2MXjslKjt7o%3D
11. B Martinez-Delgado B Melendez M Cuadros, et al. 2002 Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas Int J Cancer 102 15 9 12353228 10.1002/ijc.10618 1:CAS:528: DC%2BD38XnvFCrurk%3D
12. EA Griffiths SD Gore CM Hooker, et al. 2010 Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia Epigenetics 5 590 20671427 10.4161/epi.5.7.12558 1:CAS:528:DC%2BC3cXhsFyrtbbK
13. J Roman-Gomez A Jimenez-Velasco JA Castillejo, et al. 2004 Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia Blood 104 2492 8 15198948 10.1182/blood-2004- 03-0954 1:CAS:528:DC%2BD2cXovVegtb4%3D
14. J Roman-Gomez A Jimenez-Velasco X Agirre F Prosper A Heiniger A Torres 2005 Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis J Clin Oncol 23 7043 9 16192589 10.1200/JCO.2005.01.4944 1:CAS:528:DC%2BD2MXhtFCrsbnF
15. O Galm S Wilop J Reichelt, et al. 2004 DNA methylation changes in multiple myeloma Leukemia 18 1687 92 15318245 10.1038/sj.leu.2403434 1:CAS:528:DC%2BD2cXnvV2qsL0%3D
16. P Valent HP Horny JM Bennett, et al. 2007 Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference Leuk Res 31 727 36 17257673 10.1016/j.leukres.2006.11.009
17. Swerdllow S, Campo E, Harris NL. WHO classification of tumours of haematopoietic and lymphoid tissues: France, IARC, 2008.
18. P Greenberg C Cox MM LeBeau, et al. 1997 International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 2079 9058730 1:CAS:528:DyaK2sXhvVars70%3D
19. CG Ekmekci MI Gutiérrez AK Siraj U Ozbek K Bhatia 2004 Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia Am J Hematol 77 233 40 15495254 10.1002/ajh.20186 1:CAS:528:DC%2BD2cXhtVenurrP
20. G Domínguez JM García C Peña, et al. 2006 ΔTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1 J Clin Oncol 24 805 16380414 10.1200/JCO.2005.02.2350
21. Chunkang C, Rui Y, Feng X, et al. The roles of SDF-1/CXCR4 axis and its relationship with apoptosis in the myelodysplastic syndromes. Medical Oncology. 2010;1-7.
22. M Giachelia F D'Alņ E Fabiani, et al. 2011 Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine Leuk Res 35 465 71 20869114 10.1016/j.leukres.2010.07.022 1:CAS:528:DC%2BC3MXjtV2rtLk%3D
23. Z Zeng YX Shi IJ Samudio, et al. 2009 Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML Blood 113 6215 24 18955566 10.1182/blood-2008-05-158311 1:CAS:528:DC%2BD1MXnslSlsr8%3D
24. MF Paz MF Fraga S Avila, et al. 2003 A systematic profile of DNA methylation in human cancer cell lines Cancer Res 63 1114 12615730 1:CAS:528:DC%2BD3sXhs1agtLo%3D
25. K Schmelz M Wagner B Dörken I Tamm 2005 5-Aza-2′-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia Int J Cancer 114 683 95 15609309 10.1002/ijc.20797 1:CAS:528:DC%2BD2MXitl2qtbc%3D
26. JE Parker GJ Mufti F Rasool A Mijovic S Devereux A Pagliuca 2000 The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS Blood 96 3932 8 11090080 1:CAS:528:DC%2BD3cXosVGnurY%3D
27. R Rajapaksa N Ginzton L Rott P Greenberg 1996 Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells Blood 88 4275 8943864 1:CAS:528:DyaK28XntlKgu7s%3D
28. A Bogdanović D Trpinac G Janković V Bumbasirević M Obradović M Colović 1997 Incidence and role of apoptosis in myelodysplastic syndrome: morphological and ultrastructural assessment Leuk: Off J Leuk Soc Am Leuk Res Fund UK 11 656 10.1038/sj.leu.2400640
29. M Fontenay E Gyan 2008 Apoptotic pathways to death in myelodysplastic syndromes Haematologica 93 1288 92 18757848 10.3324/haematol.13563 1:CAS:528:DC%2BD1cXhtl2gtbfJ
30. M Rossi V De Laurenzi E Munarriz, et al. 2005 The ubiquitin-protein ligase Itch regulates p73 stability EMBO J 24 836 48 15678106 10.1038/sj.emboj.7600444 1:CAS:528:DC%2BD2MXhsFWlsLg%3D
31. MS Irwin K Kondo MC Marin LS Cheng WC Hahn WG Kaelin Jr 2003 Chemosensitivity linked to p73 function Cancer cell 3 403 10 12726865 10.1016/S1535-6108(03)00078-3 1:CAS:528:DC%2BD3sXjsFGgs78%3D
32. J Zhu S Nozell J Wang J Jiang W Zhou X Chen 2001 p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner Oncogene 20 4050 11494133 10.1038/sj.onc.1204516 1:CAS:528:DC%2BD3MXlsVent70%3D
33. T Qin EM Youssef J Jelinek, et al. 2007 Effect of cytarabine and decitabine in combination in human leukemic cell lines Clin Cancer Res 13 4225 32 17634552 10.1158/1078-0432.CCR-06-2762 1:CAS:528:DC%2BD2sXnvVChsb0%3D
34. DE Rollison N Howlader MT Smith, et al. 2008 Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs Blood 112 45 52 18443215 10.1182/blood-2008-01-134858 1:CAS:528:DC%2BD1cXotlymu7Y%3D
35. X Ma M Does A Raza ST Mayne 2007 Myelodysplastic syndromes Cancer 109 1536 42 17345612 10.1002/cncr.22570